Results 31 to 40 of about 8,068 (254)
Pediatric Blood &Cancer, EarlyView.ABSTRACT Relapsed and/or refractory (R/R) pediatric acute leukemia carries a dismal prognosis, largely driven by chemoresistance to conventional salvage therapy. The BH3‐mimetic venetoclax, combined with chemotherapy or hypomethylating agents, has demonstrated efficacy in small clinical trials.
Katherine S. Colman +9 more
wiley +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Pediatric refractory immune thrombocytopenia (rITP) is generally characterized by persistent thrombocytopenia and failure to achieve a sustained response to multiple standard therapies. We report a 4‐year‐old female with congenital tufting enteropathy, post‐intestinal transplant patient on immunosuppressants, who developed severe rITP ...
Sarah Hsieh +4 more
wiley +1 more source
Stem Cells International, 2019 Objective. To preliminary explore the senescent dynamic changes of the bone marrow mesenchymal stem cells (BMMSCs) by human ageing and its possible mechanism. Methods.
Xiongbin Chen +8 more
doaj +1 more source
Lipid composition of normal human bone marrow as determined by column chromatography*
Journal of Lipid Research, 1962 The composition of the lipids of normal human bone marrow has been determined. Marrows were obtained post-mortem from the femurs of 12 subjects ranging in age from 1 to 78 years. The total extractable lipid, which varied from 28% to 84% of the tissue wet
Paul K. Lund +2 more
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Febrile neutropenia (FN) is a frequent and serious complication in children receiving cancer therapy. Standardizing FN management across Asia is challenging due to variable healthcare infrastructure, diagnostic capacity, and infection patterns; however, it could improve resource use and patient outcomes.
Joliza Patricia Cañeba +29 more
wiley +1 more source
, 2015 Colony forming assay on 10 months old miR29ab1 knockout bone marrows (n = 8; 4 ko + 4 wt; p = 0.006).
Lauren Kauffman (765565) +6 more
core +1 more source
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...
Nosa Bazuaye +33 more
wiley +1 more source
Colony forming assay on 6 months old miR29ab1 knockout bone marrows (n = 8; 4 ko + 4 wt; p = 0.01).
, 2015 Colony forming assay on 6 months old miR29ab1 knockout bone marrows (n = 8; 4 ko + 4 wt; p = 0.01).
Lauren Kauffman (765565) +6 more
core +1 more source
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Establishing a comprehensive apheresis medicine program in a resource‐constrained setting presents significant structural, financial, and logistical challenges. Despite the growing clinical importance of apheresis services globally, published experience from sub‐Saharan Africa remains sparse.
Folasade Adelekan‐Popoola +4 more
wiley +1 more source
, 2013 A: 10 days-cultured CFU-Fs colonies stained with May Grünmwald Giemsa (a: original magnification ×50 and b: original magnification ×200). B: Proportion of CFU-Fs in irradiated bone marrows (black columns) compared to controls (grey columns).C: Absolute ...
Chantal Humblet (332380) +6 more
core +1 more source